DevOps is a culture, not just a process – Yevhen Kazmin. In our latest episode of Wild Data Podcast, we dive deep into how DevOps powers real-time AI and cloud infrastructure. Yevhen, a Senior DevOps Engineer, breaks down how CI/CD, Kubernetes, and cloud automation are shaping

Ever 🤔 wondered how a massive neural network like Meta's Llama 3.2 actually learns? It's not 🔮 magic, it's a powerful mathematical process called Gradient Descent, brilliantly visualized in this video. Think of it like this: The AI model is exploring a vast, hilly "loss

€5M Raised: @Wearebiorce Accelerates Drug Development with AI !. Barcelona-based healthtech startup Biorce has secured €5 million in new funding from Norrsken VC, Europe’s largest impact VC, to continue its mission of streamlining clinical trials and getting life-saving

People are always curious about the "magic" behind AI 🤔. As a founder who has been building in this space for a decade, I believe the most powerful insights come from understanding the fundamentals. This video beautifully illustrates those first principles. It’s a great

$140M Raised: Draig Therapeutics Launches to Transform Neuropsychiatric Treatment at the Source !. Draig Therapeutics, a clinical-stage biotech targeting the root mechanisms of neuropsychiatric disorders, has emerged from stealth with $140 million in funding — backed by an elite

Spot the difference ? Yeah, good luck — 98% fail harder at first glance 🤯 ! . #AI #Founder #Data #Startup

€4M Raised: Perci Health Expands AI-Powered Virtual Cancer Care Across the UK !. London-based Perci Health, a trailblazing virtual cancer clinic, has secured €4 million in oversubscribed funding, doubling its original target and bringing its total raised to €10.4 million —

See how neural network calculation happens ! worth watching 🧐 . #AI #startup #LLM #MVP #founder

$150M Raised: @glean Surges to $7.2B Valuation, Powering the Future of AI-First Workplaces!. Glean, the generative AI enterprise search leader, has raised $150 million in a Series F round led by Wellington Management — skyrocketing its valuation by $2.6B in under a year to $7.2

Do you remember when you joined X? I do! #MyXAnniversary

RT @Patrick18287926: Our latest work is out: we designed dual GLP1R/GCGR agonists—cyclic peptides that activate both metabolic receptors, e….

What are you working on this week ?

$54M Raised: @PactumAi Scales Agentic AI to Revolutionize Enterprise Procurement!. Pactum has secured $54 million in Series C funding led by Insight Partners, pushing total funding past $100M — and solidifying its leadership in AI-driven, autonomous procurement. 🔗 Pactum’s

What ? Where ? Ahhhhhh it's Friday ! 😂 😅 . #Friday #Fun #CEO #Founder

Fake news just got an upgrade 😬. What do you think, harmless fun or a real threat ?. It’s only been a few days since @GoogleAI dropped Veo 3, and people are already generating ultra-realistic news clips from scratch, anchors, dialogue, ambient sound, the whole package. This is

$141M Deal Signed: @Agenus_Bio & Zydus Group Partner to Advance Cancer Immunotherapies Globally!. Lexington-based Agenus Inc. has inked a landmark $141 million agreement with India’s @ZydusUniverse to accelerate the development and manufacturing of two promising cancer drugs —

$40M Raised: @vivodyne Replaces Animal Testing with AI + Robotics to Revolutionize Drug Discovery !. Philadelphia-based Vivodyne, a trailblazer in AI-powered human tissue testing, has secured $40 million in Series A funding led by Khosla Ventures, marking a decisive move to

Just watched this—and I have to say, it's genuinely worth your time 🤌 . #Founder #Entrepreneurs #Startup

$76M Secured: Juvenescence & M42 Unite to Supercharge AI-Driven Drug Discovery!. Ramsey-based Juvenescence Ltd., a clinical-stage biotech focused on age-related diseases, has raised $76 million in Series B-1 financing led by Abu Dhabi’s M42 — marking a bold leap forward in

RT @CodeByPoonam: ChatGPT is super powerful tool. But most people still don't know its full potential. Here're 10 ChatGPT features you sh….

€22.6M Secured: Tilt Bio Targets Ovarian Cancer with Immune-Oncology Breakthrough !. Helsinki-based TILT Biotherapeutics Ltd has secured €22.6 million in Series B financing to push forward its cutting-edge cancer immunotherapy trials — marking a major step toward transforming